I think I get it "Manufacturing rights". So Cephalon has the full rights to sell some of the products. But MSB will be manufacting everything they sell. So the better Cephalon does the better for us as we make X% profit on every vial made (what is a typical manufacturing mark up?).
big deal, page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.3¢ |
Change
-0.018(1.79%) |
Mkt cap ! $1.116B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.5¢ | $5.468M | 5.631M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 73050 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 168169 | 21 |
View Market Depth
| Last trade - 15.39pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |